Mauro Viganò
- Hepatology top 0.2%
- Hepatitis C virus research 80
- Liver Disease and Transplantation 22
- Hepatitis Viruses Studies and Epidemiology 12
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Epidemiology top 1%
- Hepatitis B Virus Studies 87
- Liver Disease Diagnosis and Treatment 76
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 11
- Hematology top 10%
- Genetics top 10%
-
- Organ Transplantation Techniques and Outcomes 6
Mauro Viganò
123 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 95
- Hepatology 2.2k
- Epidemiology 2.4k
- Infectious Diseases 285
- Hematology 118
- Genetics 111
Countries citing papers authored by Mauro Viganò
This map shows the geographic impact of Mauro Viganò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Viganò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Viganò more than expected).
Fields of papers citing papers by Mauro Viganò
This network shows the impact of papers produced by Mauro Viganò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Viganò. The network helps show where Mauro Viganò may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mauro Viganò, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 16 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 5 | |
| 12 | 2015 | 15 | |
| 13 | 2013 | 6 | |
| 14 | 2012 | 83 | |
| 15 | 2011 | 32 | |
| 16 | 2010 | 67 | |
| 17 | 2010 | 42 | |
| 18 | Progressive decline of HBsAg titers in longterm virological responders to nucleos(t)ide analogue therapy for chronic hepatitis B | 2008 | 1 |
| 19 | 2008 | 2 | |
| 20 | 2007 | 246 |
About Mauro Viganò
Mauro Viganò is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 131 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (87 papers), Hepatitis C virus research (80 papers), Liver Disease Diagnosis and Treatment (76 papers), Liver Disease and Transplantation (22 papers), Hepatitis Viruses Studies and Epidemiology (12 papers), HIV/AIDS drug development and treatment (11 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Hepatology (2.2k citations), Epidemiology (2.4k citations) and Infectious Diseases (285 citations). Mauro Viganò has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Pietro Lampertico, Massimo Iavarone, M. Colombo, E. Manenti, Massimo Colombo, G. Grossi, Massimo Colombo, F. Facchetti, G. Lunghi and Federica Invernizzi. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Liver International, Gastroenterology and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.